Evolv Technology Completes Restatement of Previously Issued Financial Statements and Reports Third Quarter, Fourth Quarter and Full Year 2024 Financial Results

Business Wire
29 Apr

— Company Regains Compliance with SEC Reporting and NASDAQ Listing Requirements —

— Company Achieves Positive Adjusted EBITDA1 in Q4'24 —

  • Q4'24 Revenue of $29.1 million, up 41% year-over-year
  • Q4'24 Ending ARR2 of $99.4 million, up 39% year-over-year
  • Q4'24 Adjusted EBITDA of $0.4 million
  • Q4'24 Ending RPO3 of $266.7 million

WALTHAM, Mass., April 28, 2025--(BUSINESS WIRE)--Evolv Technologies Holdings, Inc (NASDAQ: EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced financial results for the quarter and year ended December 31, 2024 and the filing of its 2024 Annual Report on Form 10-K with the U.S. Securities and Exchange Commission ("SEC"). The Company concurrently filed with the SEC its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, and restated financial results for the periods from the second quarter of 2022 through the second quarter of 2024. The restatements correct inaccurate accounting for certain sales transactions that led to premature or incorrectly recognized revenue. The errors resulted in premature or incorrect recognition of approximately $3.1 million of revenue on a net basis from the second quarter of 2022 through the second quarter of 2024 (considering revenue prematurely recognized but offset by amounts appropriately recognized in subsequent periods).

"Completing this restatement—which brings the Company back into full compliance with SEC reporting and Nasdaq listing requirements—marks an important milestone in our ongoing work to rebuild stakeholder confidence," said John Kedzierski, President and Chief Executive Officer of Evolv Technology, Inc. "Looking ahead, we are focused on prioritizing disciplined execution, transparent communication, and an unwavering commitment to best-in-class compliance. With both the restatement and the FTC resolution now firmly behind us and having achieved our long-standing profitability goals six months ahead of schedule, we believe we are well-positioned as we enter our next phase of growth. We are poised to lead the transformation of the security technology landscape—making the world a safer place where people can live, work, learn, and play."

Total revenue for the third quarter of 2024 was $27.4 million, an increase of 37% compared to $20.0 million (as restated) for the third quarter of 2023. Annual Recurring Revenue ("ARR")2 was $93.7 million at the end of third quarter of 2024, an increase of 46% compared to $64.4 million (as restated) at the end of the third quarter of 2023. Net loss for the third quarter of 2024 was $(30.4) million, or $(0.19) per basic and diluted share, compared to net income of $5.0 million (as restated), or $0.03 (as restated) per basic and diluted share, in the third quarter of 2023. Adjusted earnings (loss)1 for the third quarter of 2024 was $(6.9) million, or $(0.04) per diluted share, compared to adjusted earnings (loss)1 of $(12.4) million (as restated), or $(0.08) per diluted share, for the third quarter of 2023. Adjusted EBITDA1 for the third quarter of 2024 was $(3.0) million compared to $(11.6) million (as restated) in the third quarter of 2023. As of September 30, 2024, the Company had cash, cash equivalents, marketable securities, and restricted cash of $56.3 million and no debt.

Total revenue for the nine months ended September 30, 2024 was $74.8 million, an increase of 27% compared to $59.0 million (as restated) for the nine months ended September 30, 2023. Net loss for the nine months ended September 30, 2024 was $(38.3) million, or $(0.25) per basic and diluted share, compared to $(90.9) million (as restated), or $(0.61) (as restated) per basic and diluted share, in the nine months ended September 30, 2023. Adjusted earnings (loss)1 for the nine months ended September 30, 2024 was $(30.8) million, or $(0.20) per diluted share, compared to adjusted earnings (loss)1 of $(44.2) million (as restated), or $(0.30) (as restated) per diluted share, for the nine months ended September 30, 2023. Adjusted EBITDA1 for the nine months ended September 30, 2024 was $(21.3) million compared to $(41.6) million (as restated) in the nine months ended September 30, 2023.

Results for the Fourth Quarter of 2024

Total revenue for the fourth quarter of 2024 was $29.1 million, an increase of 41% compared to $20.6 million (as restated) for the fourth quarter of 2023. Annual Recurring Revenue ("ARR")2 was $99.4 million at the end of fourth quarter of 2024, an increase of 39% compared to $71.3 million (as restated) at the end of the fourth quarter of 2023. Net loss for the fourth quarter of 2024 was $(15.7) million, or $(0.10) per basic and diluted share, compared to net loss of $(17.2) million (as restated), or $(0.11) per basic and diluted share, in the fourth quarter of 2023. Adjusted earnings (loss)1 for the fourth quarter of 2024 was $(4.4) million, or $(0.03) per diluted share, compared to adjusted earnings (loss)1 of $(11.8) million (as restated), or $(0.08) (as restated) per diluted share, for the fourth quarter of 2023. Adjusted EBITDA1 for the fourth quarter of 2024 was $0.4 million compared to $(10.3) million (as restated) in the fourth quarter of 2023. As of December 31, 2024, the Company had cash, cash equivalents, marketable securities, and restricted cash of $51.9 million and no debt. Remaining Performance Obligation3 as of December 31, 2024 was $266.7 million. The Company had approximately 6,100 units deployed as of December 31, 2024, reflecting a one time adjustment to remove approximately (100) non-revenue generating units from the Company's deployed unit count related to Evolv Edge, the Company's first generation product offering.

Total revenue for the twelve months ended December 31, 2024 was $103.9 million, an increase of 31% compared to $79.6 million (as restated) for the twelve months ended December 31, 2023. Net loss for the twelve months ended December 31, 2024 was $(54.0) million, or $(0.34) per basic and diluted share, compared to $(108.0) million (as restated), or $(0.72) (as restated) per basic and diluted share, in the twelve months ended December 31, 2023. Adjusted earnings (loss)1 for the twelve months ended December 31, 2024 was $(35.3) million, or $(0.23) per diluted share, compared to adjusted earnings (loss)1 of $(56.0) million (as restated), or $(0.38) (as restated) per diluted share, for the twelve months ended December 31, 2023. Adjusted EBITDA1 for the twelve months ended December 31, 2024 was $(21.0) million compared to $(51.8) million (as restated) in the twelve months ended December 31, 2023.

The following table summarizes the breakdown of recurring and non-recurring revenue4 for each period presented:

Three Months Ended
December 31,

Twelve Months Ended
December 31,

2024

2023

% Change

2024

2023

% Change

(Restated)

(Restated)

Recurring revenue

$

23,678

$

17,074

39

%

$

87,419

$

50,915

72

%

Non-recurring revenue

5,422

3,506

55

%

16,446

28,650

(43

)%

Total revenue

$

29,100

$

20,580

41

%

$

103,865

$

79,565

31

%

Three Months Ended
September 30,

Nine Months Ended
September 30,

2024

2023

% Change

2024

2023

% Change

(Restated)

(Restated)

Recurring revenue

$

23,764

$

13,907

71

%

$

63,741

$

33,841

88

%

Non-recurring revenue

3,596

6,054

(41

)%

11,024

25,144

(56

)%

Total revenue

$

27,360

$

19,961

37

%

$

74,765

$

58,985

27

%

The following table summarizes operating cash flows for each period presented:

Three Months Ended
December 31,

Twelve Months Ended
December 31,

2024

2023

2024

2023

(Restated)

(Restated)

Net loss

$

(15,720

)

$

(17,198

)

$

(54,017

)

$

(108,048

)

Non-cash expense

6,870

7,461

22,504

59,199

Changes in operating assets and liabilities

12,054

6,594

660

39,048

Net cash used in operating activities

$

3,204

$

(3,143

)

$

(30,853

)

$

(9,801

)

Three Months Ended
September 30,

Nine Months Ended
September 30,

2024

2023

2024

2023

(Restated)

(Restated)

Net loss

$

(30,443

)

$

5,046

$

(38,297

)

$

(90,850

)

Non-cash expense

26,306

(16,055

)

15,634

51,738

Changes in operating assets and liabilities

7,812

13,106

(11,394

)

32,454

Net cash used in operating activities

$

3,675

$

2,097

$

(34,057

)

$

(6,658

)

About Evolv Technology

Evolv Technologies Holdings, Inc (NASDAQ: EVLV) is designed to transform human security to make a safer, faster, and better experience for the world’s most iconic venues and companies as well as schools, hospitals, and public spaces, using industry leading artificial intelligence (AI)-powered screening and analytics. Its mission is to transform security to create a safer world to live, work, learn, and play. Evolv has digitally transformed the gateways in many places where people gather by enabling seamless integration combined with powerful analytics and insights. Evolv’s advanced systems have scanned more than two billion people since 2019. Evolv has been awarded the U.S. Department of Homeland Security (DHS) SAFETY Act Designation as a Qualified Anti-Terrorism Technology (QATT) as well as the Security Industry Association (SIA) 2024 New Products and Solutions (NPS) Award in the Law Enforcement/Public Safety/Guarding Systems category, as well as Sport Business Journal’s (SBJ) 2024 awards for "Best In Fan Experience Technology" and "Best In Sports Technology". Evolv®, Evolv Express®, Evolv Insights®, Evolv Visual Gun Detection™, Evolv eXpedite™, and Evolv Eva™ are registered trademarks or trademarks of Evolv Technologies, Inc. in the United States and other jurisdictions. For more information, visit evolv.com.

1 Non-GAAP Financial Measures In this press release, the Company’s adjusted gross profit (loss), adjusted gross margin, adjusted operating expenses, adjusted operating income (loss), adjusted EBITDA, adjusted earnings (loss), and adjusted earnings per diluted share are not presented in accordance with generally accepted accounting principles (GAAP) and are not intended to be used in lieu of GAAP presentations of results of operations. Adjusted operating expenses is defined as operating expenses less stock-based compensation expense, loss on impairment of lease equipment, one-time employee separation costs, and one-time legal and regulatory costs, which management believes provides a more meaningful representation of on-going operating expense levels. One time legal and regulatory costs include one-time legal, accounting and professional fees related to the internal investigation, subsequent restatement, certain one-time regulatory, litigation and legal matters, as well as fees related to the resolution of the U.S. Federal Trade Commission investigation. Adjusted gross profit and adjusted gross margin exclude stock-based compensation expense, amortization of capitalized stock-based compensation, losses from impairment of intangible assets, one-time employee separation costs, and one-time inventory charges, which management believes provides a more meaningful representation of contribution margin. Adjusted operating loss is defined as operating loss, excluding stock-based compensation expense, amortization of capitalized stock-based compensation, losses from impairment of lease equipment and intangible assets, one-time employee separation costs, one-time inventory charges, and one-time legal and regulatory expenses, which management believes provides a more meaningful representation of operating results. Adjusted EBITDA is defined as net income (loss) plus depreciation and amortization, stock-based compensation, interest expense (income), provision for income taxes, loss on extinguishment of debt, change in fair value of contingent earn-out liability, change in fair value of contingently issuable common stock liability, change in fair value of public warrant liability, loss on impairment of lease equipment and intangible assets, one-time employee separation costs, one-time inventory charges, and one-time legal and regulatory expenses. Adjusted earnings (loss) is defined as net income (loss) plus stock-based compensation, amortization of capitalized stock-based compensation, loss on extinguishment of debt, change in fair value of contingent earn-out liability, change in fair value of contingently issuable common stock liability, change in fair value of public warrant liability, loss on impairment of lease equipment and intangible assets, one-time employee separation costs, one-time inventory charges, and one-time legal and regulatory expenses. Management presents non-GAAP financial measures because it considers them to be important supplemental measures of performance. Management uses non-GAAP financial measures for planning purposes, including analysis of the Company's performance against prior periods, the preparation of operating budgets and to determine appropriate levels of operating and capital investments. Management also believes non-GAAP financial measures provide additional insight for analysts and investors in evaluating the Company's financial and operating performance. However, non-GAAP financial measures have limitations as an analytical tool and are not intended to be an alternative to financial measures prepared in accordance with GAAP. We intend to provide non-GAAP financial measures as part of our future earnings discussions and, therefore, the inclusion of non-GAAP financial measures will provide consistency in our financial reporting. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures included in this press release. The Company is unable to provide a reconciliation of Adjusted Gross Margin to GAAP Gross Margin and Adjusted EBITDA to Net Income (Loss), each measure's most directly comparable GAAP financial measure, on a forward-looking basis without unreasonable effort, because items that impact these GAAP financial measures are not within the Company’s control and/or cannot be reasonably predicted. These items may include, but are not limited to, predicting forward-looking share-based compensation, changes in the fair value of derivative liabilities, changes in the fair value of contingent earn out liabilities, changes in the fair value of contingently issuable common stock liabilities and changes in fair value of public warrant liabilities. Such information may have a significant, and potentially unpredictable, impact on the Company’s future financial results.

2 We define Annual Recurring Revenue, or ARR, as subscription revenue and the recurring service revenue related to purchase subscriptions for the final month of the quarter normalized to a one-year period. Our calculation of ARR is not adjusted for the impact of any known or projected future events (such as customer cancellations, upgrades or downgrades, or price increases or decreases) that may cause any such contract not to be renewed on its existing terms. In addition, the amount of actual revenue that we recognize over any 12-month period is likely to differ from ARR at the beginning of that period, sometimes significantly. This may occur due to new bookings, cancellations, upgrades, downgrades or other changes in pending renewals, as well as the effects of professional services revenue and acquisitions or divestitures. As a result, ARR should be viewed independently of, and not as a substitute for or forecast of, revenue and deferred revenue. Our calculation of ARR may differ from similarly titled metrics presented by other companies.

3 We define Remaining Performance Obligation, or RPO, as estimated revenues expected to be recognized in the future related to performance obligations that are unsatisfied or partially satisfied as of the end of the quarter.

4 Recurring revenue includes the recurring portion of revenue associated with pure subscription contracts and hardware purchase subscription contracts. Non-recurring revenue includes revenue that is one-time in nature, such as product revenue, shipping revenue, and revenue from installation, training, and professional services.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this press release and related presentation materials other than statements of historical facts, including without limitation statements regarding our strategy, commitments, and future financial and operational results. Words such as "believe" "may," "will," "expect," "should," "could," "anticipate," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "project," "plan," "target," "forecast", "is/are likely to" or the negative of these terms or other similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. The forward-looking statements in this press release and related presentation materials are only predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the following: relating to our history of losses and ability to reach profitability; our reliance on reseller partners to generate a growing portion of our revenue; expectations regarding the Company’s strategies and future financial performance, including its future business plans or objectives, prospective performance and opportunities and competitors, revenues, products and services, pricing, operating expenses, market trends, liquidity, cash flows and uses of cash, capital expenditures; the Company’s reliance on third party contract manufacturing and distribution, and a global supply chain; the Company recognizes a substantial portion of its revenue ratably over the term of its agreements, and, as a result, downturns or upturns in sales may not be immediately reflected in its operating results; the rate of innovation required to maintain competitiveness in the markets in which the Company competes; the competitiveness of the market in which the Company competes; the failure of our products to detect threats could result in injury or loss of life, which could harm our brand, reputation, and results of operations; the loss of designation of our Evolv Express® system as a Qualified Anti-Terrorism Technology under the Homeland Security SAFETY Act; risks related to our business model, which is predicated, in part, on building a customer base that will generate a recurring stream of revenues through the sale of our subscription contracts; the ability for the Company to obtain, maintain, protect and enforce the Company’s intellectual property rights and use of "open source" software; the concentration of the Company’s revenues on a single solution; the Company’s ability to timely design, produce and launch its solutions, the Company’s ability to invest in growth initiatives and pursue acquisition opportunities; the limited liquidity and trading of the Company’s securities; risks related to existing and changing tax laws; geopolitical risk and changes in applicable laws or regulations; the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors; operational risk; risks related to material weaknesses in our internal control over financial reporting and our remediation plans; risks related to increasing attention to and evolving expectations for, environmental, social, and governance initiatives; the impact of fluctuating general economic and market conditions and reductions in spending; the need for additional capital to support business growth, which might not be available on acceptable terms, if at all; and litigation and regulatory enforcement risks, including the diversion of management time and attention and the additional costs and demands on resources. These and other important factors discussed under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2024 filed with the Securities and Exchange Commission ("SEC") on April 28, 2025, could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. The forward-looking statements in this press release and related presentation materials are based upon information available to us as of the date hereof, and while we believe such information forms a reasonable basis for such statements, it may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements.

You should review this press release and the documents that we reference in this press release and related presentation materials with the understanding that our actual future results, levels of activity, performance and achievements may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained in this press release and related presentation materials, whether as a result of any new information, future events or otherwise.

 

EVOLV TECHNOLOGY

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(In thousands, except share and per share data)

 

Three Months Ended
December 31,

Twelve Months Ended
December 31,

2024

2023

2024

2023

(Restated)

(Restated)

Revenue:

Product revenue

$

1,675

$

1,848

$

6,464

$

22,768

Subscription revenue

17,263

12,468

65,046

36,201

Service revenue

6,564

4,856

23,467

15,606

License fee and other revenue

3,598

1,408

8,888

4,990

Total revenue

29,100

20,580

103,865

79,565

Cost of revenue:

Cost of product revenue

2,166

4,692

10,735

27,967

Cost of subscription revenue

8,604

4,984

27,846

14,760

Cost of service revenue

1,476

1,166

5,399

3,982

Cost of license fee and other revenue

113

177

597

949

Total cost of revenue

12,359

11,019

44,577

47,658

Gross profit

16,741

9,561

59,288

31,907

Operating expenses:

Research and development

5,390

6,303

23,446

24,473

Sales and marketing

13,455

14,344

61,291

54,986

General and administrative

16,759

11,128

56,634

42,182

Loss from impairment of property and equipment

15

224

322

Total operating expenses

35,619

31,775

141,595

121,963

Loss from operations

(18,878

)

(22,214

)

(82,307

)

(90,056

)

Other income (expense), net:

Interest expense

(654

)

Interest income

548

1,630

2,942

6,227

Other expense, net

(50

)

(17

)

(83

)

(84

)

Loss on extinguishment of debt

(626

)

Change in fair value of contingent earn-out liability

1,218

2,452

16,310

(14,901

)

Change in fair value of contingently issuable common stock liability

311

422

2,529

(3,138

)

Change in fair value of public warrant liability

1,131

580

6,592

(4,765

)

Total other income (expense), net

3,158

5,067

28,290

(17,941

)

Loss before income taxes

(15,720

)

(17,147

)

(54,017

)

(107,997

)

Provision for income taxes

(51

)

$

$

(51

)

Net loss

$

(15,720

)

$

(17,198

)

$

(54,017

)

$

(108,048

)

Net income (loss) attributable to common stockholders – basic and diluted

$

(15,720

)

$

(17,198

)

$

(54,017

)

$

(108,048

)

Weighted average common shares outstanding

Basic

158,997,410

151,087,430

156,573,886

149,168,105

Diluted

158,997,410

151,087,430

156,573,886

149,168,105

Net loss per share

Basic

$

(0.10

)

$

(0.11

)

$

(0.34

)

$

(0.72

)

Diluted

$

(0.10

)

$

(0.11

)

$

(0.34

)

$

(0.72

)

Weighted average common shares outstanding – basic and diluted

158,997,410

151,087,430

156,573,886

149,168,105

Net loss per share - basic and diluted

$

(0.10

)

$

(0.11

)

$

(0.34

)

$

(0.72

)

Net loss

$

(15,720

)

$

(17,198

)

$

(54,017

)

$

(108,048

)

Other comprehensive income (loss)

Cumulative translation adjustment

96

(44

)

21

(43

)

Total other comprehensive income (loss)

96

(44

)

21

(43

)

Total comprehensive loss

$

(15,624

)

$

(17,242

)

$

(53,996

)

$

(108,091

)

...
 

EVOLV TECHNOLOGY

CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per share data)

 

December 31, 2024

December 31, 2023

(Restated)

Assets

Current assets:

Cash and cash equivalents

$

37,015

$

67,162

Restricted cash

275

Marketable securities

14,927

51,289

Accounts receivable, net

28,392

21,547

Inventory

16,963

10,344

Current portion of contract assets

799

1,397

Current portion of commission asset

5,429

4,387

Prepaid expenses and other current assets

17,921

16,957

Total current assets

121,446

173,358

Contract assets, noncurrent

657

964

Commission asset, noncurrent

7,567

7,249

Property and equipment, net

123,661

113,161

Operating lease right-of-use assets

13,993

1,195

Other assets

735

1,202

Total assets

$

268,059

$

297,129

Liabilities and Stockholders’ Equity

Current liabilities:

Accounts payable

$

10,492

$

17,400

Accrued expenses and other current liabilities

19,508

15,703

Current portion of deferred revenue

64,506

46,808

Current portion of operating lease liabilities

2,203

1,391

Total current liabilities

96,709

81,302

Deferred revenue, noncurrent

20,266

25,149

Operating lease liabilities, noncurrent

12,326

Contingent earn-out liability

12,809

29,119

Contingently issuable common stock liability

4,001

6,530

Public warrant liability

4,297

10,889

Total liabilities

150,408

152,989

Stockholders’ equity:

Preferred stock, $0.0001 par value; 100,000,000 authorized at December 31, 2024 and December 31, 2023; no shares issued and outstanding at December 31, 2024 and December 31, 2023

Common stock, $0.0001 par value; 1,100,000,000 shares authorized at December 31, 2024 and December 31, 2023; 159,602,069 and 151,310,080 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively

16

15

Additional paid-in capital

472,331

444,825

Accumulated other comprehensive loss

(32

)

(53

)

Accumulated deficit

(354,664

)

(300,647

)

Stockholders’ equity

117,651

144,140

Total liabilities and stockholders’ equity

$

268,059

$

297,129

EVOLV TECHNOLOGY
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)

 
 

Twelve Months Ended
December 31,

2024

2023

(Restated)

Cash flows from operating activities:

Net loss

$

(54,017

)

$

(108,048

)

Adjustments to reconcile net loss to net cash used in operating activities:

Depreciation and amortization

17,375

9,702

Write-off of inventory and change in inventory reserve

2,578

1,309

Loss from impairment of property and equipment

224

322

Loss from impairment of intangible asset

983

Stock-based compensation

24,756

24,129

Non-cash interest expense

22

Amortization (accretion) of premium (discount) on marketable securities, net of change in accrued interest

447

(575

)

Non-cash lease expense

1,420

478

Change in allowance for expected credit losses

152

382

Loss on extinguishment of debt

626

Change in fair value of earn-out liability

(16,310

)

14,901

Change in fair value of contingently issuable common stock

(2,529

)

3,138

Change in fair value of public warrant liability

(6,592

)

4,765

Changes in operating assets and liabilities

Accounts receivable

(6,997

)

4,510

Inventory

(7,852

)

960

Commission assets

(1,360

)

(2,779

)

Contract assets

905

1,383

Other assets

467

633

Prepaid expenses and other current assets

(964

)

(2,426

)

Accounts payable

192

(5,963

)

Deferred revenue

12,815

39,488

Accrued expenses and other current liabilities

4,534

3,857

Operating lease liability

(1,080

)

(615

)

Net cash used in operating activities

(30,853

)

(9,801

)

Cash flows from investing activities:

Development of internal-use software

(6,125

)

(3,535

)

Purchases of property and equipment

(31,189

)

(69,134

)

Proceeds from sale of property and equipment

270

Purchases of marketable securities

(29,367

)

(89,898

)

Proceeds from maturities of marketable securities

65,282

39,184

Net cash provided by (used in) investing activities

(1,399

)

(123,113

)

Cash flows from financing activities:

Proceeds from exercise of stock options

1,809

668

Proceeds from long-term debt

1,876

Repayment of principal on long-term debt

(31,876

)

Payment of debt issuance costs and prepayment penalty

(332

)

Net cash provided by (used in) financing activities

1,809

(29,664

)

Effect of exchange rate changes on cash and cash equivalents

21

(43

)

Net decrease in cash, cash equivalents and restricted cash

(30,422

)

(162,621

)

Cash, cash equivalents and restricted cash

Cash, cash equivalents and restricted cash at beginning of period

67,437

230,058

Cash, cash equivalents and restricted cash at end of period

$

37,015

$

67,437

 
 

EVOLV TECHNOLOGY

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

(In thousands, except share and per share data)

(Unaudited

 

Three Months Ended
September 30,

Nine Months Ended
September 30,

2024

2023

2024

2023

(Restated)

(Restated)

Revenue:

Product revenue

$

1,344

$

3,456

$

4,789

$

20,920

Subscription revenue

17,909

9,858

47,783

23,733

Service revenue

6,085

4,345

16,903

10,750

License fee and other revenue

2,022

2,302

5,290

3,582

Total revenue

27,360

19,961

74,765

58,985

Cost of revenue:

Cost of product revenue

2,616

3,496

8,569

23,275

Cost of subscription revenue

7,348

4,157

19,242

9,776

Cost of service revenue

1,404

1,219

3,923

2,816

Cost of license fee and other revenue

183

198

484

772

Total cost of revenue

11,551

9,070

32,218

36,639

Gross profit

15,809

10,891

42,547

22,346

Operating expenses:

Research and development

5,810

6,386

18,056

18,170

Sales and marketing

14,966

14,408

47,836

40,642

General and administrative

13,976

11,261

39,875

31,054

Loss from impairment of property and equipment

209

28

209

322

Total operating expenses

34,961

32,083

105,976

90,188

Loss from operations

(19,152

)

(21,192

)

(63,429

)

(67,842

)

Other income (expense), net:

Interest expense

(654

)

Interest income

628

1,791

2,394

4,597

Other income (expense), net

34

(64

)

(33

)

(67

)

Loss on extinguishment of debt

(626

)

Change in fair value of contingent earn-out liability

(8,321

)

14,078

15,092

(17,353

)

Change in fair value of contingently issuable common stock liability

(2,056

)

2,277

2,218

(3,560

)

Change in fair value of public warrant liability

(1,576

)

8,156

5,461

(5,345

)

Total other (expense) income, net

(11,291

)

26,238

25,132

(23,008

)

Net (loss) income

$

(30,443

)

$

5,046

$

(38,297

)

$

(90,850

)

Net (loss) income attributable to common stockholders – basic and diluted

$

(30,443

)

$

4,983

$

(38,297

)

$

(90,850

)

Weighted average common shares outstanding

Basic

157,709,229

150,206,893

155,760,149

148,521,299

Diluted

157,709,229

173,976,375

155,760,149

148,521,299

Net (loss) income per share

Basic

$

(0.19

)

$

0.03

$

(0.25

)

$

(0.61

)

Diluted

$

(0.19

)

$

0.03

$

(0.25

)

$

(0.61

)

Net (loss) income

$

(30,443

)

$

5,046

$

(38,297

)

$

(90,850

)

Other comprehensive (loss) income

Cumulative translation adjustment

(86

)

34

(75

)

1

Total other comprehensive (loss) income

(86

)

34

(75

)

1

Total comprehensive (loss) income

$

(30,529

)

$

5,080

$

(38,372

)

$

(90,849

)

 

EVOLV TECHNOLOGY

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per share data)

(Unaudited)

 

September 30, 2024

December 31, 2023

(Restated)

Assets

Current assets:

Cash and cash equivalents

$

46,033

$

67,162

Restricted cash

275

275

Marketable securities

9,960

51,289

Accounts receivable, net

34,855

21,547

Inventory

16,276

10,344

Current portion of contract assets

696

1,397

Current portion of commission asset

5,256

4,387

Prepaid expenses and other current assets

21,050

16,957

Total current assets

134,401

173,358

Contract assets, noncurrent

672

964

Commission asset, noncurrent

7,385

7,249

Property and equipment, net

120,842

113,161

Operating lease right-of-use assets

14,297

1,195

Other assets

869

1,202

Total assets

$

278,466

$

297,129

Liabilities and Stockholders’ Equity

Current liabilities:

Accounts payable

$

8,619

$

17,400

Accrued expenses and other current liabilities

17,016

15,703

Current portion of deferred revenue

61,649

46,808

Current portion of operating lease liabilities

2,191

1,391

Total current liabilities

89,475

81,302

Deferred revenue, noncurrent

23,867

25,149

Operating lease liabilities, noncurrent

12,372

Contingent earn-out liability

14,027

29,119

Contingently issuable common stock liability

4,312

6,530

Public warrant liability

5,428

10,889

Total liabilities

149,481

152,989

Stockholders’ equity:

Preferred stock, $0.0001 par value; 100,000,000 authorized at September 30, 2024 and December 31, 2023; no shares issued and outstanding at September 30, 2024 and December 31, 2023

Common stock, $0.0001 par value; 1,100,000,000 shares authorized at September 30, 2024 and December 31, 2023; 158,288,746 and 151,310,080 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively

16

15

Additional paid-in capital

468,041

444,825

Accumulated other comprehensive loss

(128

)

(53

)

Accumulated deficit

(338,944

)

(300,647

)

Stockholders’ equity

128,985

144,140

Total liabilities and stockholders’ equity

$

278,466

$

297,129

 

EVOLV TECHNOLOGY

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

 

Nine Months Ended
September 30,

2024

2023

(Restated)

Cash flows from operating activities:

Net loss

$

(38,297

)

$

(90,850

)

Adjustments to reconcile net loss to net cash used in operating activities:

Depreciation and amortization

11,933

6,570

Write-off of inventory and change in inventory reserve

3,151

278

Loss from impairment of property and equipment

209

322

Stock-based compensation

21,364

17,771

Non-cash interest expense

22

Amortization (accretion) of premium (discount) on marketable securities, net of change in accrued interest

261

(482

)

Non-cash lease expense

1,116

136

Change in allowance for expected credit losses

371

237

Loss on extinguishment of debt

626

Change in fair value of earn-out liability

(15,092

)

17,353

Change in fair value of contingently issuable common stock

(2,218

)

3,560

Change in fair value of public warrant liability

(5,461

)

5,345

Changes in operating assets and liabilities

Accounts receivable

(13,679

)

(929

)

Inventory

(8,327

)

4,170

Commission assets

(1,005

)

(2,102

)

Contract assets

993

(85

)

Other assets

333

352

Prepaid expenses and other current assets

(4,093

)

(1,973

)

Accounts payable

216

(6,396

)

Deferred revenue

13,559

39,357

Accrued expenses and other current liabilities

1,655

278

Operating lease liability

(1,046

)

(218

)

Net cash used in operating activities

(34,057

)

(6,658

)

Cash flows from investing activities:

Development of internal-use software

(4,773

)

(2,202

)

Purchases of property and equipment

(24,443

)

(51,646

)

Proceeds from sale of property and equipment

60

Purchases of marketable securities

(14,567

)

(58,652

)

Proceeds from maturities of marketable securities

55,635

19,647

Net cash provided by (used in) investing activities

11,852

(92,793

)

Cash flows from financing activities:

Proceeds from exercise of stock options

1,151

616

Proceeds from long-term debt

1,876

Repayment of principal on long-term debt

(31,876

)

Payment of debt issuance costs and prepayment penalty

(332

)

Net cash provided by (used in) financing activities

1,151

(29,716

)

Effect of exchange rate changes on cash and cash equivalents

(75

)

1

Net decrease in cash, cash equivalents and restricted cash

(21,129

)

(129,166

)

Cash, cash equivalents and restricted cash

Cash, cash equivalents and restricted cash at beginning of period

67,437

230,058

Cash, cash equivalents and restricted cash at end of period

$

46,308

$

100,892

 

EVOLV TECHNOLOGY

SUMMARY OF KEY OPERATING STATISTICS

(Unaudited)

 

Three Months Ended or as of,

($ in thousands)

March 31,
2024

June 30,
2024

September 30,
2024

December 31,
2024

New customers

53

84

52

60

Annual recurring revenue

$

79,192

$

87,011

$

93,676

$

99,351

Recurring revenue

$

18,961

$

21,016

$

23,764

$

23,678

Total net units shipped*

375

447

468

458

 

*Net Units Shipped reflects total units shipped (excluding rental units, upgrade units, etc.) less units churned.

 

EVOLV TECHNOLOGY

RECONCILIATION OF GAAP OPERATING EXPENSES TO ADJUSTED OPERATING EXPENSES

(In thousands)

(Unaudited)

 

Three Months Ended,

March 31,
2023

June 30,
2023

September 30,
2023

December 31,
2023

March 31,
2024

June 30,
2024

September 30,
2024

December 31,
2024

(Restated)

(Restated)

(Restated)

(Restated)

(Restated)

(Restated)

Operating expenses, GAAP

$

27,098

$

31,007

$

32,083

$

31,775

$

34,061

$

36,954

$

34,961

$

35,619

Stock-based compensation

(4,888

)

(6,518

)

(5,922

)

(6,218

)

(6,292

)

(7,254

)

(7,263

)

(3,159

)

Loss on impairment of lease equipment

(137

)

(157

)

(28

)

(209

)

(15

)

One-time employee separation costs

(282

)

(61

)

(262

)

(826

)

(2,059

)

Other one-time legal and regulatory costs

(53

)

(401

)

(884

)

(273

)

(476

)

(2,185

)

(2,339

)

(7,285

)

Adjusted operating expenses

$

22,020

$

23,649

$

25,188

$

25,022

$

27,293

$

26,689

$

25,150

$

23,101

 

EVOLV TECHNOLOGY

RECONCILIATION OF GAAP GROSS PROFIT TO ADJUSTED GROSS PROFIT, GAAP GROSS MARGIN TO ADJUSTED GROSS MARGIN AND GAAP OPERATING INCOME (LOSS) TO ADJUSTED OPERATING INCOME (LOSS)

(In thousands)

(Unaudited)

 

Three Months Ended
December 31,

Twelve Months Ended
December 31,

2024

2023

2024

2023

(Restated)

(Restated)

Revenue

$

29,100

$

20,580

$

103,865

$

79,565

Cost of revenue

12,359

11,019

44,577

47,658

Gross profit, GAAP

16,741

9,561

59,288

31,907

Stock-based compensation

233

140

788

583

Amortization of capitalized stock-based compensation

85

14

137

47

Loss from impairment of intangible asset

983

983

One-time employee separation costs

174

One-time inventory charges

123

1,925

2,729

1,925

Adjusted gross profit

$

18,165

$

11,640

$

64,100

$

34,462

Gross margin %

57.5

%

46.5

%

57.1

%

40.1

%

Adjusted gross margin %

62.4

%

56.6

%

61.7

%

43.3

%

Three Months Ended
September 30,

Nine Months Ended
September 30,

2024

2023

2024

2023

(Restated)

(Restated)

Revenue

$

27,360

$

19,961

$

74,765

$

58,985

Cost of revenue

11,551

9,070

32,218

36,639

Gross profit, GAAP

15,809

10,891

42,547

22,346

Stock-based compensation

244

114

555

443

Amortization of capitalized stock-based compensation

23

12

52

33

One-time employee separation costs

174

One-time inventory charges

1,471

2,607

Adjusted gross profit

$

17,547

$

11,017

$

45,935

$

22,822

Gross margin %

57.8

%

54.6

%

56.9

%

37.9

%

Adjusted gross margin %

64.1

%

55.2

%

61.4

%

38.7

%

Three Months Ended
December 31,

Twelve Months Ended
December 31,

2024

2023

2024

2023

(Restated)

(Restated)

Operating loss, GAAP

$

(18,878

)

$

(22,214

)

$

(82,307

)

$

(90,056

)

Stock-based compensation

3,392

6,358

24,756

24,129

Amortization of capitalized stock-based compensation

85

14

137

47

Loss on impairment of lease equipment

15

224

322

Loss from impairment of intangible asset

983

983

One-time employee separation costs

2,060

262

3,060

605

One-time inventory charges

123

1,925

2,729

1,925

Other one-time legal and regulatory costs

7,284

273

12,285

1,611

Adjusted operating loss

$

(4,936

)

$

(13,382

)

$

(38,133

)

$

(61,417

)

Three Months Ended
September 30,

Nine Months Ended
September 30,

2024

2023

2024

2023

(Restated)

(Restated)

Operating loss, GAAP

$

(19,152

)

$

(21,192

)

$

(63,429

)

$

(67,842

)

Stock-based compensation

7,507

6,036

21,364

17,771

Amortization of capitalized stock-based compensation

23

12

52

33

Loss on impairment of lease equipment

209

28

209

322

One-time employee separation costs

61

1,000

343

One-time inventory charges

1,471

2,607

Other one-time legal and regulatory costs

2,339

884

5,000

1,338

Adjusted operating loss

$

(7,603

)

$

(14,171

)

$

(33,197

)

$

(48,035

)

 

EVOLV TECHNOLOGY

RECONCILIATION OF GAAP NET INCOME (LOSS) TO ADJUSTED EBITDA

(In thousands)

(Unaudited)

 

Three Months Ended
December 31,

Twelve Months Ended
December 31,

2024

2023

2024

2023

(Restated)

(Restated)

Net loss

$

(15,720

)

$

(17,198

)

$

(54,017

)

$

(108,048

)

Depreciation & amortization

5,442

3,132

17,375

9,702

Stock-based compensation

3,392

6,358

24,756

24,129

Interest expense (income)

(548

)

(1,630

)

(2,942

)

(5,573

)

Provision for income taxes

51

51

Loss on extinguishment of debt

626

Change in fair value of contingent earn-out liability

(1,218

)

(2,452

)

(16,310

)

14,901

Change in fair value of contingently issuable common stock liability

(311

)

(422

)

(2,529

)

3,138

Change in fair value of public warrant liability

(1,131

)

(580

)

(6,592

)

4,765

Loss on impairment of lease equipment

15

224

322

Loss from impairment of intangible asset

983

983

One-time employee separation costs

2,060

262

3,060

605

One-time inventory charges

123

1,925

2,729

1,925

Other one-time legal and regulatory costs

7,284

273

12,285

1,611

Adjusted EBITDA

$

371

$

(10,281

)

$

(20,978

)

$

(51,846

)

Three Months Ended
September 30,

Nine Months Ended
September 30,

2024

2023

2024

2023

(Restated)

(Restated)

Net (loss) income

$

(30,443

)

$

5,046

$

(38,297

)

$

(90,850

)

Depreciation & amortization

4,575

2,620

11,933

6,570

Stock-based compensation

7,507

6,036

21,364

17,771

Interest expense (income)

(628

)

(1,791

)

(2,394

)

(3,943

)

Loss on extinguishment of debt

626

Change in fair value of contingent earn-out liability

8,321

(14,078

)

(15,092

)

17,353

Change in fair value of contingently issuable common stock liability

2,056

(2,277

)

(2,218

)

3,560

Change in fair value of public warrant liability

1,576

(8,156

)

(5,461

)

5,345

Loss on impairment of lease equipment

209

28

209

322

One-time employee separation costs

61

1,000

343

One-time inventory charges

1,471

2,607

Other one-time legal and regulatory costs

2,339

884

5,000

1,338

Adjusted EBITDA

$

(3,017

)

$

(11,627

)

$

(21,349

)

$

(41,565

)

 

EVOLV TECHNOLOGY

RECONCILIATION OF GAAP NET INCOME (LOSS) TO ADJUSTED EARNINGS (LOSS)

(In thousands, except share and per share data)

(Unaudited)

 

Three Months Ended
December 31,

Twelve Months Ended
December 31,

2024

2023

2024

2023

(Restated)

(Restated)

Net loss

$

(15,720

)

$

(17,198

)

$

(54,017

)

$

(108,048

)

Stock-based compensation

3,392

6,358

24,756

24,129

Amortization of capitalized stock-based compensation

85

14

137

47

Loss on extinguishment of debt

626

Change in fair value of contingent earn-out liability

(1,218

)

(2,452

)

(16,310

)

14,901

Change in fair value of contingently issuable common stock liability

(311

)

(422

)

(2,529

)

3,138

Change in fair value of public warrant liability

(1,131

)

(580

)

(6,592

)

4,765

Loss on impairment of lease equipment

15

224

322

Loss from impairment of intangible asset

983

983

One-time employee separation costs

2,060

262

3,060

605

One-time inventory charges

123

1,925

2,729

1,925

Other one-time legal and regulatory costs

7,284

273

12,285

1,611

Adjusted loss

$

(4,438

)

$

(11,820

)

$

(35,274

)

$

(55,979

)

Weighted average common shares outstanding – diluted

158,997,410

151,087,430

156,573,886

149,168,105

Adjusted loss per share – diluted

$

(0.03

)

$

(0.08

)

$

(0.23

)

$

(0.38

)

Three Months Ended
September 30,

Nine Months Ended
September 30,

2024

2023

2024

2023

(Restated)

(Restated)

Net (loss) income

$

(30,443

)

$

5,046

$

(38,297

)

$

(90,850

)

Stock-based compensation

7,507

6,036

21,364

17,771

Amortization of capitalized stock-based compensation

23

12

52

33

Loss on extinguishment of debt

626

Change in fair value of contingent earn-out liability

8,321

(14,078

)

(15,092

)

17,353

Change in fair value of contingently issuable common stock liability

2,056

(2,277

)

(2,218

)

3,560

Change in fair value of public warrant liability

1,576

(8,156

)

(5,461

)

5,345

Loss on impairment of lease equipment

209

28

209

322

One-time employee separation costs

61

1,000

343

One-time inventory charges

1,471

2,607

Other one-time legal and regulatory costs

2,339

884

5,000

1,338

Adjusted loss

$

(6,941

)

$

(12,444

)

$

(30,836

)

$

(44,159

)

Weighted average common shares outstanding – diluted

157,709,229

150,206,893

155,760,149

148,521,299

Adjusted loss per share – diluted

$

(0.04

)

$

(0.08

)

$

(0.20

)

$

(0.30

)

*In the consolidated statements of operations, one-time inventory reserves were recorded in cost of product revenue and one-time legal and regulatory costs were recorded in general and administrative expense. Stock-based compensation, amortization of capitalized stock-based compensation, and one-time employee termination costs were recorded as follows. Prior period amounts are being shown for comparative purposes:

Three Months Ended,

March 31,
2023

June 30,
2023

September 30,
2023

December 31,
2023

March 31,
2024

June 30,
2024

September 30,
2024

December 31,
2024

(Restated)

(Restated)

(Restated)

(Restated)

(Restated)

(Restated)

Stock-based compensation:

Cost of product revenue

$

16

$

12

$

$

6

$

$

5

$

4

$

8

Cost of subscription revenue

52

82

74

82

91

110

169

154

Cost of service revenue

47

61

38

47

44

51

63

61

Cost of license fee and other revenue

31

28

2

5

3

7

8

10

Research and development

843

1,232

1,148

1,079

902

1,222

1,243

1,153

Sales and marketing

1,980

2,536

2,293

2,572

2,959

2,724

2,516

2,747

General and administrative

2,065

2,750

2,481

2,567

2,431

3,308

3,504

(741

)

Total stock-based compensation

$

5,034

$

6,701

$

6,036

$

6,358

$

6,430

$

7,427

$

7,507

$

3,392

Amortization of capitalized stock-based compensation:

Cost of subscription revenue

5

5

6

8

8

8

13

47

Cost of service revenue

5

6

6

6

6

7

10

38

Total amortization of capitalized stock-based compensation

$

10

$

11

$

12

$

14

$

14

$

15

$

23

$

85

One-time employee separation costs:

Cost of service revenue

$

$

$

$

$

$

174

$

$

Sales and marketing

282

61

262

794

63

General and administrative

32

1,997

Total other one-time expenses

$

$

282

$

61

$

262

$

$

1,000

$

$

2,060

View source version on businesswire.com: https://www.businesswire.com/news/home/20250428860927/en/

Contacts

Investor Relations:
Brian Norris
Senior Vice President of Finance and Investor Relations
bnorris@evolvtechnology.com


Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10